政策法规 | Clinical Pharmacology Considerations for the Development ofOligonucleotide Therapeutics: Guidance for Industry 资料来源：Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics | FDA 返回列表 >
